AusBiotech
AusBiotech is Australia's peak body for the life sciences, a not-for-profit industry association serving 3,500+ members across research, biotech, medtech, and government. It delivers membership, commercialisation advisory via the government-funded Industry Growth Program, flagship conferences, and policy advocacy.
- Company typePrivate
- Founded1985
- HeadquartersSouth Yarra, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What AusBiotech does
AusBiotech is Australia's peak body for the life sciences, operating as a not-for-profit membership organisation founded in 1985 and headquartered in South Yarra, Melbourne. It represents Australia's full life sciences ecosystem — research, translation, development, commercialisation, manufacturing, and global trade — through a 3,500+ member community spanning universities, medical research institutes, start-ups, scale-ups, SMEs, large Australian enterprises, international companies, hospitals and healthcare providers, CROs, CDMOs, service providers, investors, and government agencies. The organisation is governed by a Board of Directors chaired by Dr James Campbell, with CEO Rebekah Cassidy leading day-to-day operations, and employs 11-50 staff.
The organisation does not develop proprietary technology. Its core service portfolio comprises (1) a tiered membership program, (2) the Australian Government-funded Industry Growth Program (IGP) delivered as an Industry Partner Organisation for commercialisation advisory (scaling to 43 companies in 2026), (3) the AusBiotech Investment platform including the Investment Readiness Panel and AusBiotech Invest conference, (4) trade facilitation through Austrade partnerships (TradeStart and Trade Diversification Network), (5) flagship events consolidated under 'Australia's Biggest Week in Biotech' combining the AusBiotech International Conference, AusMedtech, and AusBiotech Invest, and (6) policy advocacy, advisory groups, and industry reports.
Revenue is generated through recurring membership subscriptions and conference/event registration and sponsorship; specific pricing and revenue figures are not publicly disclosed. AusBiotech occupies a position analogous to a trade association with quasi-regulatory convening authority, distinguished from competitors by 40 years of brand recognition, formal designation as a government Industry Partner Organisation, and CSL-level enterprise participation on its Board.
AusBiotech firmographics
Firmographics- Name
- AusBiotech
- Legal name
- AusBiotech
- Website
- https://ausbiotech.org
- Company type
- Private
- Founded year
- 1985
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AusBiotech is Australia's peak body for the life sciences, a not-for-profit industry association serving 3,500+ members across research, biotech, medtech, and government. It delivers membership, commercialisation advisory via the government-funded Industry Growth Program, flagship conferences, and policy advocacy.
- Ownership category
- akta.pro rank
Where AusBiotech is headquartered
LocationHeadquarters
- HQ city
- South Yarra
- HQ country
- Australia
- HQ region
- Oceania
Markets served
AusBiotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Membership subscriptions: AusBiotech generates revenue primarily through membership fees from its 3,500+ members spanning universities, research institutes, startups, SMEs, large companies, international companies, healthcare providers, CROs, service providers, investors, government agencies, and CDMOs.
- Conference and event registration: Major revenue stream from hosting flagship events including AusBiotech International Conference, AusMedtech, AusBiotech Invest, and the combined 'Biggest Week in Biotech'. Events attract thousands of delegates from across Australia and internationally.
Go-to-market motion1 record
Distribution channels6 records
Marketing channels6 records
AusBiotech product offering
Product offeringCore offering
AusBiotech is Australia's peak body for the life sciences sector, operating as a not-for-profit membership organization with more than 3,500 members spanning researchers, universities, medical research institutes, start-ups, scale-ups, SMEs, large Australian and international companies, hospitals, CROs, CDMOs, service providers, investors, and government agencies. The organization delivers policy advocacy, industry convening, flagship conferences, commercialization advisory through the Industry Growth Program (IGP), investor readiness support through AusBiotech Investment programs, and trade facilitation through partnerships with Austrade (TradeStart and Trade Diversification Network).
Product overview
AusBiotech is Australia's peak industry body for life sciences, operating as a not-for-profit membership organization rather than a product company. The organization offers a portfolio of programs and services including membership (3,500 members), the Australian Government-funded Industry Growth Program (IGP) for commercialization advisory, AusBiotech Investment programs including the Investment Readiness Panel and AusBiotech Invest conference, TradeStart and Trade Diversification Network partnerships with Austrade for export support, flagship conferences (AusBiotech International Conference, AusMedtech, AusBiotech Invest), the Women in Life Sciences program with Medicines Australia, Advisory Groups and State Committees, and industry reports and publications. These programs collectively support Australia's life sciences ecosystem from early-stage discovery through to translation, development, commercialisation, manufacturing, and global trade.
Differentiator
Problem solved
Functional benefit
Brands
- AusMedtech: Australia's leading medical technology conference, bringing together medtech industry leaders for collaboration and sector development.
- AusBiotech Invest
- AusBiotech International Conference
- Women in Life Sciences
- Industry Growth Program (IGP)
- TradeStart
- AusBiotech Investment
- Biotech Dispatch
Products and services
- Membership Services Membership program serving 3,500+ members across Australia's life sciences ecosystem, including universities, medical research institutes, startups, scale-ups, SMEs, large Australian and international companies, hospitals and healthcare providers, CROs, service providers, investors, government agencies, CDMOs, and clinicians/academics/students. Members access advocacy, networking, policy engagement, and program benefits.
- Industry Growth Program (IGP)
Quantifiable outcome
- Sector doubled in size since 2017 with 2,900 organisations and 1,600 biotech and medtech companies
- +2 more outcomes
Companies that use AusBiotech
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
AusBiotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AusBiotech partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and strategic.
- Bio NSW, Life Sciences Queensland, BioMelbourne Network, Life Sciences WAcoreNine peak health and medical technology industry bodies including AusBiotech, Bio NSW, Life Sciences Queensland, BioMelbourne Network, Life Sciences WA, and others sent joint letter to Treasurer Jim Chalmers opposing proposed R&D tax incentive and capital gains tax reforms affecting the sector.
- TenmilecoreStrategic partnership announced during AusMedtech Day Two by AusBiotech CEO Rebekah Cassidy and Tenmile Managing Director Dr Steve Burnell. Partnership aims to accelerate and strengthen the Australian life sciences sector by combining resources and expertise. Focus areas include anti-microbial resistance, cancer, AI, women's health and health equity. Tenmile's Focal Point and Healthtech Muster events will feature within Australia's Biggest Week in Biotech.
- Medicines AustraliacoreJoint advocacy partnership endorsing the 'Ambitious Australia: Strategic Examination of R&D Final Report'. Both organizations have partnered on multiple initiatives including the Women in Life Sciences Luncheon and Leadership Summit, and the jointly established Advanced Therapies Advisory Group for Australia's cell and gene therapy sector.
- Proto AxiomstrategicNational partnership signed to strengthen coordination across investor-focused programs connecting researchers, investors, and industry. Proto Axiom is a Sydney-based life sciences company creator and biotech investment incubator.
- SMART CRC (Solutions for Manufacturing Advanced Regenerative Therapies)coreSMART CRC CEO Professor Simon Cool serves as inaugural Chair of the Advanced Therapies Advisory Group jointly established by AusBiotech and Medicines Australia. SMART CRC represents 63 partners advancing Australia's regenerative therapy manufacturing capability.
- Austrade Trade Diversification NetworkcoreAusBiotech selected to join Austrade's newly established Trade Diversification Network, part of the $50 million Accessing New Markets Initiative (ANMI). The Network consists of 40 national peak bodies working to help Australian businesses diversify and grow internationally.
- Taiwan Bio Industry OrganizationstrategicMOU signed to strengthen global life sciences collaboration. Formalises partnership between Australia's peak life sciences body and Taiwan's bio industry organization, supporting cross-border collaboration and partnership opportunities.
- Austrade (Australian Trade and Investment Commission)corePartnership through the national TradeStart network delivering export and growth support for Australian life sciences companies. AusBiotech is the first life sciences peak body to join with Austrade as a national partner in delivering TradeStart. The partnership established a new National TradeStart Adviser role embedded within AusBiotech's team.
- ANDHealthcorePartnership agreement with Australia's premier provider of commercialisation support for digital and connected health technologies. Aims to enhance collaboration on mutual interests and support ongoing industry innovation. Targets the fastest growing field in health and life science technology.
- MTPConnectcoreJoint pre-budget submission calling for investment in strategic initiatives to boost Australia's life sciences sector. Partnership also includes joint advocacy for Australia-UK BioBridge and collaboration on Cell and Gene Catalyst initiatives.
Scale indicators11 records
Recent moves6 records
Expansion highlights7 records
AusBiotech competitors and assessment
Company assessmentDirect peers
- MTPConnect: Australia's Medical Technologies and Pharmaceuticals Industry Growth Centre, established under the same federal Industry Growth framework AusBiotech operates within. Co-submits pre-budget submissions with AusBiotech and collaborates on Cell and Gene Catalyst initiatives — a closely aligned industry development counterpart.
- Life Sciences Queensland: Queensland's peak life sciences industry body and fellow coalition member in joint RDTI advocacy with AusBiotech. Serves the same member archetypes (researchers, startups, SMEs, investors) at a state level and competes/cooperates with AusBiotech for Queensland member engagement.
- ANDHealth: Australia's premier commercialisation provider for digital and connected health technologies and a strategic partner of AusBiotech. Both organisations deliver commercialisation advisory and ecosystem convening for Australian health technology companies, serving overlapping member cohorts with complementary programs.
- BioMelbourne Network: Victoria's peak industry body for life sciences and a fellow signatory to the joint letter opposing RDTI reforms. Operates as a state-level counterpart to AusBiotech, convening similar member segments (researchers, startups, investors) within Victoria and competing for member engagement at a sub-national level.
- Medicines Australia: Australia's peak industry body for the innovative medicines sector and AusBiotech's most direct peer. Both organisations are national not-for-profit peak bodies representing life sciences in Australia, jointly advocate on RDTI/CGT policy, and co-deliver the Women in Life Sciences program and the Advanced Therapies Advisory Group.
- BioIndustry Association (BIA): The UK's national trade association for the biotechnology and life sciences sector, a counterpart to AusBiotech's role in Australia. Provides the closest international analog to AusBiotech's advocacy, convening, and investment facilitation mandate — and a peer referenced in the Australia-UK BioBridge collaboration discussions.
- BIOTECanada: Canada's national biotechnology industry association performing the equivalent peak-body function for the Canadian life sciences sector. Mirrors AusBiotech's advocacy, convening, and member-service mandate with similar member segmentation and revenue model (membership + events).
- Bio NSW: New South Wales' peak industry organisation for life sciences and a fellow coalition member with AusBiotech on joint RDTI policy submissions. Operates as a state-level peer serving overlapping NSW-based members, providing similar networking and advocacy services at the sub-national level.
Regional players
- Swiss Biotech Association: Switzerland's national biotechnology industry association representing the Swiss biotech ecosystem. A regional peer performing a similar peak-body role in a different geography, with comparable membership, advocacy, and event-driven engagement models relevant for AusBiotech's international benchmarking.
Broad incumbents
- Biotechnology Innovation Organization (BIO): The world's largest biotechnology trade association, representing 1,000+ members across the US and globally. Comparable to AusBiotech in mandate (advocacy, events including the BIO Convention, investor engagement) but at vastly greater scale and serving a much larger, US-anchored member base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
AusBiotech social profiles
Digital presenceAusBiotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
AusBiotech leadership team
Management profileNumber of profiles
Profiles9 records
AusBiotech funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AusBiotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AusBiotech
What does AusBiotech do?
AusBiotech is Australia's peak body for the life sciences sector, operating as a not-for-profit membership organization with more than 3,500 members spanning researchers, universities, medical research institutes, start-ups, scale-ups, SMEs, large Australian and international companies, hospitals, CROs, CDMOs, service providers, investors, and government agencies. The organization delivers policy advocacy, industry convening, flagship conferences, commercialization advisory through the Industry Growth Program (IGP), investor readiness support through AusBiotech Investment programs, and trade facilitation through partnerships with Austrade (TradeStart and Trade Diversification Network).
Is AusBiotech a public or private company?
AusBiotech is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was AusBiotech founded?
AusBiotech was founded in 1985. It employs 11 to 50 people.
Where is AusBiotech based?
AusBiotech is headquartered in South Yarra, Australia, in the Oceania region.
How does AusBiotech make money?
Two revenue lines are on record. Membership subscriptions are the primary driver. The others are conference and event registration.
Who are AusBiotech's main competitors?
Direct peers on record are MTPConnect, Life Sciences Queensland, ANDHealth, BioMelbourne Network, Medicines Australia, BioIndustry Association (BIA), BIOTECanada and Bio NSW. Swiss Biotech Association is listed as a regional player. Biotechnology Innovation Organization (BIO) is listed as a broad incumbent.
Does AusBiotech have an API?
No public API is recorded for AusBiotech.